HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

pegaspargase (Oncaspar)

covalent attachment of PEG to enzyme produces active, stable complex; non-immunogenic; used in treatment of leukemia
Also Known As:
Oncaspar; PEG-asparaginase; pegylated asparaginase; pegylated-L-asparaginase; polyethyleneglycol-asparaginase
Networked: 299 relevant articles (39 outcomes, 50 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Devidas, Meenakshi: 12 articles (10/2021 - 02/2006)
2. Hunger, Stephen P: 12 articles (10/2021 - 07/2013)
3. Zhang, Mingzhi: 9 articles (01/2022 - 11/2014)
4. Carroll, William L: 9 articles (10/2021 - 07/2013)
5. Loh, Mignon L: 9 articles (10/2021 - 07/2015)
6. Raetz, Elizabeth A: 9 articles (10/2021 - 07/2015)
7. Li, Xin: 8 articles (01/2022 - 09/2013)
8. Schmiegelow, Kjeld: 8 articles (01/2022 - 01/2015)
9. Winick, Naomi J: 8 articles (10/2021 - 07/2013)
10. Rizzari, Carmelo: 7 articles (03/2022 - 01/2006)

Related Diseases

1. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
2. Lymphoma (Lymphomas)
3. Hypersensitivity (Allergy)
4. Leukemia
5. Extranodal NK-T-Cell Lymphoma

Related Drugs and Biologics

1. Dexamethasone (Maxidex)
2. Methotrexate (Mexate)
3. Asparaginase (Elspar)
4. Gemcitabine
5. Etoposide (VP 16)
6. pegaspargase (Oncaspar)
7. Cisplatin (Platino)
8. Asparagine
9. Vincristine (Oncovin)
10. Ifosfamide

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Premedication
3. Radiotherapy
4. Therapeutics
5. Induction Chemotherapy